← Back to headlines
Inhibikase Therapeutics Reports GAAP EPS of -$0.49
Inhibikase Therapeutics has released its financial results, reporting a GAAP Earnings Per Share of -$0.49.
26 Mar, 20:36 — 26 Mar, 20:36
Sources
Showing 1 of 1 sources
Inhibikase Therapeutics has released its financial results, reporting a GAAP Earnings Per Share of -$0.49.
